August 16, 2022
COLUMBIA, Md. — Shimadzu Scientific Instruments introduces the EDX-7200 energy dispersive X-ray fluorescence spectrometer for fast, accurate detection and analysis of elements in samples. The EDX-7200 fluorescence spectrometer is equipped with a high-resolution silicon drift detector (SDD) to achieve a higher count rate and detection efficiency than its predecessor models. The EDX-7200 incorporates a high-count-rate [...]
Bright Giant GmbH and Agilent Technologies Announce Collaboration: Innovation for Identification
August 16, 2022
JENA, Germany -- Bright Giant GmbH and Agilent Technologies are excited to announce their new product development collaboration, designed to enhance non-targeted metabolomics workflows using AI-based methods and empower scientists to make novel, impactful discoveries. This collaboration aims to combine Bright Giant’s expertise in artificial intelligence solutions for small molecule research with Agilent’s state-of-the-art mass [...]
AMSBIO expand range of Laminin isoforms
August 16, 2022
Designed to efficiently induce differentiation in ES and iPS cells, AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include isoforms LN-111 and LN-332. This expanded range of laminin isoforms (LN-111, 332, 511, 411 and 221) now provides even greater flexibility and control when tailoring your substrate to the requirements of specific cultured cells. Proven in many [...]
August 16, 2022
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled [...]
Minderoo Foundation and Illumina Commit $40M AUD to Apply Advanced Genomics to Marine Conservation
August 16, 2022
New partnership will use the power of high-throughput sequencing to measure and understand marine life in our oceans at a rate that eclipses traditional research methods SAN DIEGO -- Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific [...]
August 16, 2022
New partnership delivers clinically proven products and manufacturing processes for advanced therapies. We announced a new strategic partnership today with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services. The partnership creates an end-to-end solution for the development and production of hMSC and exosome therapeutics leveraging RoosterBio’s [...]
August 15, 2022
Session will showcase the rapidly growing use and groundbreaking impact of clinical genomics in oncology SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature Dr. Karen Knudsen, CEO of the American Cancer Society, at its inaugural Illumina Genomics Forum (IGF) on October 1. [...]
New recruitment to increase Qlucore’s sales.
August 15, 2022
Nasdaq First North-listed Qlucore has recently appointed Fredrik Hellborg to strengthen sales within the diagnostics segment. Hellborg comes from Qiagen, where he was Market Development Manager for Clinical Genomics and Personalized healthcare. His focus is to establish Qlucore's software in the clinical cancer diagnostics market. He takes up the position on 15 August. Fredrik Hellborg [...]
August 12, 2022
EAST SYRACUSE, N.Y. -- INFICON, a global leader in advanced instrumentation designed for fast, on-site detection of chemical agents and other industrial applications, today announced that it has been awarded a contract from the General Services Administration (GSA) to supply its field-portable, HAPSITE ® chemical identification systems to the U.S. Government. The award includes a [...]
August 12, 2022
Real-world trial with US Law Enforcement of new Illicit Drug Detection Device for Fentanyl Tucson, AZ — Lightsense Technology, a pioneer in developing multi-spectroscopic solutions to address large problems in public health—from the opioid crisis to pandemics and even food safety —announced today a new field test of its DrugDetect-F1 device (for the safe and [...]

